Executive Summary Chief Medical Officer with expertise in developing and managing private and public biotechnology companies focused on accelerating translation of biomolecular advances and technologies into innovative products with high clinical utility and impact on disease outcomes.Professional Background• Emphasis on translational medicine to enhance disease stratification and clinical decision-making by integrating molecular discoveries with bioinformatic-driven analysis of patient records and scientific datasets to develop clinical algorithms• Advocacy and achievement of corporate objectives by developing collaborative partnerships and relationships with academicians, practitioners, biotechnology and pharmaceutical companies, health systems, payers, the NIH and the FDA • Application of unique physician-scientist perspectives acquired at UCSF to prioritize and satisfy challenging healthcare needs by integrating expertise in disease biology, genomics and proteomics, and technology platforms with decades of patient management experience• Contribution of creative problem-solving skills and strategies to enhance executive teamwork, engage and communicate with the board of directors, and facilitate private and public fundraising interactions with venture capitalists and investors• Management of cross-functional, matrix biotechnology teams to design and execute complex work flows; define and solve complex problems; and establish and achieve aggressive project milestones and timelines.• Collaborative leadership style with peers and project teams to drive success along the spectrum from early stage preclinical science to late stage product validation and commercialization • Experience in diverse disease indications, including oncology, cardiology, pulmonary medicine, intensive care medicine, autoimmunity, inflammation, fibrosis, neurodegenerative diseases and transplantation immunobiology.
Listed skills include Biotechnology, Clinical Development, Medicine, Translational Research, and 19 others.
